GlobeNewswire

SparkLabs Engages with Argon Group to Launch the First Startup Accelerator Security Token Offering

Dela

The Largest Accelerator Network in Asia Partners with Argon Group, a leading digital finance advisory firm, and Swarm.Fund, the first security token platform, to Democratize Venture Capital Access

 

PALO ALTO, Calif., May 11, 2018 (GLOBE NEWSWIRE) -- SparkLabs Group, which has the largest accelerator network in Asia and operates global venture capital funds, has engaged with Argon Group, a leading digital finance advisory firm, to launch the first startup accelerator security token offering through their Smart City & Smart Planet Fund (sparklabs.tokenhub.com).

The SparkLabs token is not a utility token and is simply a smart contract that represents an investor's ("Limited Partners") equity into its fund vehicle that will have equal holdings in start-up companies that are associated with SparkLabs IoT & Smart City Accelerator in Songdo, South Korea and SparkLabs Cultiv8 Accelerator in Orange, Australia.

"SparkLabs has been very conservative in our approach and viewpoints on the cryptocurrency space and token offerings.  We have been concerned that many utility tokens are in fact securities and have viewed this space with some trepidation.  After meticulous diligence, we have now decided to jump into the pool a bit with a security token offering that we believe is conservative and provides a better understanding for venture capitalists on how this can affect our industry in the years to come," stated Jimmy Kim, Co-founder of SparkLabs Group and former CFO of Nexon (South Korea's largest onling gaming company).  Additionally, Mr. Kim's most recent startup, N3N, was Cisco's first IoT investment.

Graduates of SparkLabs accelerators have an average raise size of over $3.5 million with 80% of the startups receiving funding after the program.  SparkLabs' startups also average over $500,000 in funds raised prior to entering the accelerator programs.

"We believe our Smart City & Smart Planet Fund allows people across the globe to invest into two accelerator funds that can truly change the world in terms of urban innovation, innovation in agriculture, and how we interact with our planet. Both accelerators have excellent partners, such as Australia's Government of New South Wales which generously provided access to over 30,000 acres of farmland for our startups to utilize as a test bed," explained Frank Meehan, Co-founder of SparkLabs Group.  Mr. Meehan was born and raised in Australia and is currently living in London. Prior to launching SparkLabs, he was best known for leading DeepMind's Series A (acquired by Google) and sat on Siri's board of directors until it was acquired by Apple.

"Argon Group is excited to be working with SparkLabs on this new and creative development for venture capital.  I believe that SparkLabs is an imaginative accelerator, and, in my view, it comes as no surprise to me that they are leading an effort combining both pioneering urban and environment planning and an innovative approach to capital raising,"  said Elliot Han, Managing Director at Argon Group.

About SparkLabs Group
SparkLabs Group (www.sparklabsgroup.com) is comprised of SparkLabs accelerator network, one of Asia's premier startup accelerators; SparkLabs Global Ventures, a leading global seed stage fund; SparkLabs Ventures, a localized early-stage fund (Series A & B) in South Korea; SparkLabs Capital, a late stage investment vehicle.  SparkLabs accelerator network consists of SparkLabs Korea (Seoul), SparkLabs China (Beijing and launching Shanghai, Chengdu and Shenzen), SparkLabs IoT & Smart Cities (Songdo, South Korea), SparkLabs Taipei, SparkLabs Cultiv8 (Sydney) and Ping An FinTech Accelerator, Powered by SparkLabs (Shenzhen & Hong Kong).

About Argon Group
Argon Group is a leading boutique investment bank focused exclusively on the digital finance and token-based capital markets. Argon Group has developed an end-to-end offering, supporting the full process of raising capital in digital capital markets as well as aftermarket trading and support.  Key clients include Blockchain Capital, Civic, Storj, Science Blockchain, Protos, TheKey and others.

About Swarm Fund
Swarm Fund is a blockchain-based resource for private equity. It's a fully decentralized capital market place that democratizes investing by using the power of the blockchain to open up alternative investment classes to investors through funds using cryptocurrency tokens. It makes traditionally exclusive investment opportunities, such as private equity and hedge funds, inclusive for the Swarm by pooling together smaller investments into larger, institutional-sized blocks, providing fund managers access to arguably untapped capital stack. 

The Swarm blockchain allows real world investment opportunities to be "tokenized" using the SRC20 protocol, a cryptographic standard for security tokens.

Contact:            
Bernard Moon, Co-founder, SparkLabs Group
+1-650-454-5244 or bernard@sparklabsglobal.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SparkLabs via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum